Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis D Mauri, N Pavlidis, JPA Ioannidis Journal of the National Cancer Institute 97 (3), 188-194, 2005 | 1561 | 2005 |
Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up FA Peccatori, HA Azim, R Orecchia, HJ Hoekstra, N Pavlidis, V Kesic, ... Annals of oncology 24, vi160-vi170, 2013 | 950 | 2013 |
Diagnostic and therapeutic management of cancer of an unknown primary N Pavlidis, E Briasoulis, J Hainsworth, FA Greco European journal of cancer 39 (14), 1990-2005, 2003 | 848 | 2003 |
Coexistence of pregnancy and malignancy NA Pavlidis The oncologist 7 (4), 279-287, 2002 | 783 | 2002 |
Cancer of unknown primary site N Pavlidis, G Pentheroudakis The Lancet 379 (9824), 1428-1435, 2012 | 628 | 2012 |
Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in … E Ioachim, A Charchanti, E Briasoulis, V Karavasilis, H Tsanou, ... European journal of cancer 38 (18), 2362-2370, 2002 | 394 | 2002 |
Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis D Mauri, N Pavlidis, NP Polyzos, JPA Ioannidis Journal of the National Cancer Institute 98 (18), 1285-1291, 2006 | 387 | 2006 |
Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies HA Azim Jr, L Santoro, N Pavlidis, S Gelber, N Kroman, H Azim, ... European journal of cancer 47 (1), 74-83, 2011 | 374 | 2011 |
Cancer and pregnancy: poena magna, not anymore G Pentheroudakis, N Pavlidis European Journal of Cancer 42 (2), 126-140, 2006 | 364 | 2006 |
Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up K Fizazi, FA Greco, N Pavlidis, G Daugaard, K Oien, G Pentheroudakis Annals of Oncology 26, v133-v138, 2015 | 350 | 2015 |
Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer: A Hellenic Co-operative Oncology Group study DV Skarlos, E Samantas, P Kosmidis, G Fountzilas, M Angelidou, ... Annals of Oncology 5 (7), 601-607, 1994 | 327 | 1994 |
Switching benchmarks in cancer of unknown primary: from autopsy to microarray G Pentheroudakis, V Golfinopoulos, N Pavlidis European journal of cancer 43 (14), 2026-2036, 2007 | 317 | 2007 |
Docetaxel (Taxotere®): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck G Catimel, J Verweij, V Mattijssen, A Hanauske, M Piccart, J Wanders, ... Annals of oncology 5 (6), 533-537, 1994 | 317 | 1994 |
Carcinoma of unknown primary (CUP) N Pavlidis, K Fizazi Critical reviews in oncology/hematology 69 (3), 271-278, 2009 | 309 | 2009 |
Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies HA Azim Jr, L Santoro, W Russell-Edu, G Pentheroudakis, N Pavlidis, ... Cancer treatment reviews 38 (7), 834-842, 2012 | 298 | 2012 |
Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: hematological … HA Azim Jr, N Pavlidis, FA Peccatori Cancer treatment reviews 36 (2), 110-121, 2010 | 297 | 2010 |
Depression in cancer: the many biobehavioral pathways driving tumor progression B Bortolato, TN Hyphantis, S Valpione, G Perini, M Maes, G Morris, ... Cancer treatment reviews 52, 58-70, 2017 | 289 | 2017 |
Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series RM Schultz, NA Pavlidis, WA Stylos, MA Chirigos Science 202 (4365), 320-321, 1978 | 265 | 1978 |
Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study E Briasoulis, H Kalofonos, D Bafaloukos, E Samantas, G Fountzilas, ... | 254 | 2000 |
Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments M Kyrgiou, G Salanti, N Pavlidis, E Paraskevaidis, JPA Ioannidis Journal of the National Cancer Institute 98 (22), 1655-1663, 2006 | 243 | 2006 |